Cabozantinib plus atezolizumab in advanced and progressive neoplasms of the endocrine system: A multicohort phase II trial (CABATEN trial / GETNE-T1914)

Simple item page
dc.conference.dateSEP 16-21, 2021
dc.conference.titleCongress of the European-Society-for-Medical-Oncology (ESMO)
dc.contributor.authorGrande, E.
dc.contributor.authorGarcia-Carbonero, R.
dc.contributor.authorTeule, A.
dc.contributor.authorBenavent Vinuales, M.
dc.contributor.authorJimenez-Fonseca, P.
dc.contributor.authorMolina-Cerrillo, J.
dc.contributor.authorLopez, C.
dc.contributor.authorCustodio, A.
dc.contributor.authorHierro, C.
dc.contributor.authorGallego, J.
dc.contributor.authorAlonso, V.
dc.contributor.authorCarmona-Bayonas, A.
dc.contributor.authorLlanos, M.
dc.contributor.authorSevilla, I.
dc.contributor.authorHernando, J.
dc.contributor.authorLista, F.
dc.contributor.authorAnton Pascual, B.
dc.contributor.authorRuffinelli, J. C.
dc.contributor.authorGallego Jimenez, I.
dc.contributor.authorCapdevila, J.
dc.contributor.authoraffiliation[Grande, E.] MD Anderson Canc Ctr Madrid, Dept Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Garcia-Carbonero, R.] UCM, Hosp Univ Octubre 12, Dept Med Oncol, Imas 12, Madrid, Spain
dc.contributor.authoraffiliation[Anton Pascual, B.] UCM, Hosp Univ Octubre 12, Dept Med Oncol, Imas 12, Madrid, Spain
dc.contributor.authoraffiliation[Teule, A.] Inst Catala Oncol ICO IDIBELL, Dept Med Oncol, Lhospitalet De Llobregat, Spain
dc.contributor.authoraffiliation[Ruffinelli, J. C.] Inst Catala Oncol ICO IDIBELL, Dept Med Oncol, Lhospitalet De Llobregat, Spain
dc.contributor.authoraffiliation[Benavent Vinuales, M.] Univ Hosp Virgen del Rocio, Inst Biomed Sevilla IBIS, Dept Med Oncol, Seville, Spain
dc.contributor.authoraffiliation[Gallego Jimenez, I.] Univ Hosp Virgen del Rocio, Inst Biomed Sevilla IBIS, Dept Med Oncol, Seville, Spain
dc.contributor.authoraffiliation[Jimenez-Fonseca, P.] Hosp Univ Cent Asturias, Dept Med Oncol, ISPA, Oviedo, Spain
dc.contributor.authoraffiliation[Molina-Cerrillo, J.] Hosp Univ Ramon & Cajal, Dept Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Lopez, C.] Hosp Univ Marques de Valdecilla, Dept Med Oncol, IDIVAL, Santander, Spain
dc.contributor.authoraffiliation[Custodio, A.] Hosp Univ La Paz, Dept Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Hierro, C.] Germans Trias & Pujol Univ Hosp, Dept Med Oncol, Catalan Inst Oncol ICO Badalona, Badalona, Spain
dc.contributor.authoraffiliation[Gallego, J.] Gen Univ Elche Hosp, Dept Med Oncol, Alicante, Spain
dc.contributor.authoraffiliation[Alonso, V.] Hosp Univ Miguel Servet, Inst Aragones Invest Sanitaria, Dept Med Oncol, Zaragoza, Spain
dc.contributor.authoraffiliation[Carmona-Bayonas, A.] IMIB, Hosp Univ Morales Meseguer, Hematol & Med Oncol Dept, UMI, Murcia, Spain
dc.contributor.authoraffiliation[Llanos, M.] Hosp Univ Canarias, Dept Med Oncol, San Cristobal La Laguna, Spain
dc.contributor.authoraffiliation[Sevilla, I.] Hosp Univ Reg & Virgen Victoria Malaga, Dept Med Oncol, Inst Invest Biomed Malaga IBIMA, Invest Clin & Traslac Canc, Malaga, Spain
dc.contributor.authoraffiliation[Hernando, J.] Vall Hebron Univ Hosp, Vall Hebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Capdevila, J.] Vall Hebron Univ Hosp, Vall Hebron Inst Oncol VHIO, Dept Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Lista, F.] MD Anderson Canc Ctr Madrid, Dept Urol, Madrid, Spain
dc.contributor.funderIpsen
dc.contributor.funderRoche
dc.date.accessioned2025-01-07T15:18:09Z
dc.date.available2025-01-07T15:18:09Z
dc.date.issued2021-09-21
dc.identifier.doi10.1016/j.annonc.2021.08.710
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttps://doi.org/10.1016/j.annonc.2021.08.710
dc.identifier.urihttps://hdl.handle.net/10668/27029
dc.identifier.wosID700527701039
dc.issue.number5
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen de la Victoria
dc.organizationSAS - Hospital Universitario Regional de Málaga
dc.organizationInstituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
dc.organizationInstituto de Investigación Biomédica de Sevilla (IBIS)
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numberS624-S625
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titleCabozantinib plus atezolizumab in advanced and progressive neoplasms of the endocrine system: A multicohort phase II trial (CABATEN trial / GETNE-T1914)
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number32
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Virgen de la Victoria
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)
Instituto de Investigación Biomédica de Málaga - Plataforma Bionand (IBIMA)
Instituto de Investigación Biomédica de Sevilla (IBIS)
SAS - Hospital Universitario Virgen del Rocío

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía